Influence of proton pump inhibitors and H2-receptor antagonists on the efficacy and safety of dasatinib in chronic myeloid leukemia patients.
Int J Hematol
; 111(6): 826-832, 2020 Jun.
Article
in En
| MEDLINE
| ID: mdl-32152877
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Drug Interactions
/
Proton Pump Inhibitors
/
Dasatinib
/
Histamine H2 Antagonists
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Int J Hematol
Journal subject:
HEMATOLOGIA
Year:
2020
Type:
Article
Affiliation country:
Japan